These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 12874978)

  • 1. Giving your spinout the right spin.
    McElroy D
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE39-41. PubMed ID: 12874978
    [No Abstract]   [Full Text] [Related]  

  • 2. Convincing a venture capitalist to invest in your idea.
    Dooley JF; Dooley JF
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE45-8. PubMed ID: 12874980
    [No Abstract]   [Full Text] [Related]  

  • 3. Filters for preparing to meet a venture capitalist.
    Christoffersen R
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE49-50. PubMed ID: 12874981
    [No Abstract]   [Full Text] [Related]  

  • 4. Selling out.
    Martin JF
    Nat Biotechnol; 2010 Apr; 28(4):315-7. PubMed ID: 20383912
    [No Abstract]   [Full Text] [Related]  

  • 5. Marriage guidance for collaborators.
    Hogan J
    Med Device Technol; 2005 Mar; 16(2):25-6. PubMed ID: 15828497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Michigan's next wave of biopharmaceutical entrepreneurship.
    Kerppola R; van de Walle M; Surine S
    Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575
    [No Abstract]   [Full Text] [Related]  

  • 7. Hybrid rigor mortis.
    Nat Biotechnol; 2003 Jun; 21(6):585. PubMed ID: 12776128
    [No Abstract]   [Full Text] [Related]  

  • 8. Making your genes come true.
    Tomlinson E
    Nat Biotechnol; 1998 May; 16 Suppl():48-9. PubMed ID: 9591270
    [No Abstract]   [Full Text] [Related]  

  • 9. Hybrid vigor.
    Williams K
    Nat Biotechnol; 2003 Aug; 21(8):843. PubMed ID: 12894189
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 11. Writing your business plan.
    Cohen L
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE33-5. PubMed ID: 12089584
    [No Abstract]   [Full Text] [Related]  

  • 12. Benefits of biotech clusters questioned.
    Sheridan C
    Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
    [No Abstract]   [Full Text] [Related]  

  • 13. For success, focus your strengths.
    Levinson AD
    Nat Biotechnol; 1998 May; 16 Suppl():45-6. PubMed ID: 9591268
    [No Abstract]   [Full Text] [Related]  

  • 14. Biologist aims to ease the pain for entrepreneurs.
    Gewin V
    Nature; 2006 Apr; 440(7085):738-9. PubMed ID: 16598227
    [No Abstract]   [Full Text] [Related]  

  • 15. Who took the tech out of biotech?
    Silverman E
    Nat Biotechnol; 2006 Mar; 24(3):255-6. PubMed ID: 16525373
    [No Abstract]   [Full Text] [Related]  

  • 16. Earlier stage biotechs attract partners.
    Ratner M
    Nat Biotechnol; 2005 May; 23(5):509. PubMed ID: 15877052
    [No Abstract]   [Full Text] [Related]  

  • 17. Assets for mastering media relations.
    Steinerman P
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE59-61. PubMed ID: 12874984
    [No Abstract]   [Full Text] [Related]  

  • 18. Five IP tips to spread your business wings.
    Cullem JG
    Nat Biotechnol; 2008 Nov; 26(11):1217-9. PubMed ID: 19009693
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyseq-Variagenics merger signals end of the line.
    Hodgson J
    Nat Biotechnol; 2003 Jan; 21(1):5. PubMed ID: 12511895
    [No Abstract]   [Full Text] [Related]  

  • 20. Boutiques reborn in 2003.
    Surendran A
    Nat Biotechnol; 2004 Mar; 22(3):353-4. PubMed ID: 15017987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.